ImClone Investigational Site is a clinical research site located in Seattle, Washington, United States 98109.
Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.
ImClone Investigational Site has participated in 16 clinical trials.
Therapeutic areas: Advanced Solid Tumors, Ovarian Cancer, Fallopian Tube Cancer.
Sponsors: Eli Lilly and Company.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Washington · View every site in Seattle
Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
ImClone Investigational Site has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
ImClone Investigational Site has 16 clinical trials on record. Their work covers Advanced Solid Tumors, Ovarian Cancer, Fallopian Tube Cancer.
ImClone Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.